Hemolytic-uremic syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


===Discovery===
===Discovery===
*[[Hemolytic-uremic syndrome|HUS]] was first  described by Gasser and colleagues  in paper published in 1955<ref name=":0">{{Cite journal
*[[Hemolytic-uremic syndrome|HUS]] was first  described by Gasser and colleagues  in paper published in 1955<ref>{{Cite journal
| author = [[A. Schieppati]], [[P. Ruggenenti]], [[R. P. Cornejo]], [[F. Ferrario]], [[G. Gregorini]], [[P. Zucchelli]], [[E. Rossi]] & [[G. Remuzzi]]
| title = Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome
| journal = [[Journal of the American Society of Nephrology : JASN]]
| volume = 2
| issue = 11
| pages = 1640–1644
| year = 1992
| month = May
| pmid = 1610985
}}</ref><ref name=":0">{{Cite journal
  | author = [[Phillip I. Tarr]], [[Carrie A. Gordon]] & [[Wayne L. Chandler]]
  | author = [[Phillip I. Tarr]], [[Carrie A. Gordon]] & [[Wayne L. Chandler]]
  | title = Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
  | title = Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome

Revision as of 14:12, 20 August 2018

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome historical perspective

CDC on Hemolytic-uremic syndrome historical perspective

Hemolytic-uremic syndrome historical perspective in the news

Blogs on Hemolytic-uremic syndrome historical perspective

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • HUS was first described by Gasser and colleagues in paper published in 1955[1][2] .
  • The association between Shiga-toxin-producing bacteria and HUS was made during 35 years ago[2].
  • In 1983, Karmali and colleagueswas the first to discover the association between Escherichia coli and the development of HUS[2].
  • In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].

Outbreaks

There have been several outbreaks of [disease name], which are summarized below:

Landmark Events in the Development of Treatment Strategies

In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Impact on Cultural History

Famous Cases

The following are a few famous cases of disease name:

References

  1. A. Schieppati, P. Ruggenenti, R. P. Cornejo, F. Ferrario, G. Gregorini, P. Zucchelli, E. Rossi & G. Remuzzi (1992). "Renal function at hospital admission as a prognostic factor in adult hemolytic uremic syndrome. The Italian Registry of Haemolytic Uremic Syndrome". Journal of the American Society of Nephrology : JASN. 2 (11): 1640–1644. PMID 1610985. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 2.2 Phillip I. Tarr, Carrie A. Gordon & Wayne L. Chandler (2005). "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome". Lancet (London, England). 365 (9464): 1073–1086. doi:10.1016/S0140-6736(05)71144-2. PMID 15781103. Unknown parameter |month= ignored (help)

Template:WH Template:WS